Last Updated: August 3, 2026

FROVATRIPTAN SUCCINATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Frovatriptan Succinate, and when can generic versions of Frovatriptan Succinate launch?

Frovatriptan Succinate is a drug marketed by Amneal Pharms Co, Glenmark Pharms Ltd, Leading, Pharmobedient, and Renata. and is included in five NDAs.

The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Frovatriptan Succinate

A generic version of FROVATRIPTAN SUCCINATE was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for FROVATRIPTAN SUCCINATE?
  • What are the global sales for FROVATRIPTAN SUCCINATE?
  • What is Average Wholesale Price for FROVATRIPTAN SUCCINATE?
Summary for FROVATRIPTAN SUCCINATE
US Patents:0
Applicants:5
NDAs:5
Paragraph IV (Patent) Challenges for FROVATRIPTAN SUCCINATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FROVA Tablets frovatriptan succinate 2.5 mg 021006 1 2011-03-09

US Patents and Regulatory Information for FROVATRIPTAN SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 211292-001 Nov 6, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmobedient FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 202931-001 Aug 28, 2014 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Leading FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 216998-001 Apr 16, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Renata FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 213891-001 Apr 6, 2022 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.